5:17pm: The team update does have some bad news: Sale has received a platelet-rich plasma treatment and will be shut down for at least six weeks. He’ll be reevaluated at that time.
Whether there’s any possibility of Sale appearing in the postseason isn’t known. But with less than six weeks to go before the end of the regular season, it’s now certain he will not be able to help the club make a last-ditch run at sneaking into Wild Card position.
The update doesn’t fill in any blanks regarding the underlying issues in the joint. But given the course of treatment, it seems reasonable to presume that the medical team has identified something beyond inflammation alone.
Precisely what is wrong with Sale’s elbow isn’t yet clear. But it seems that a visit to Dr. James Andrews did not reveal anything beyond the inflammation that initially sent the southpaw to the injured list.
We’ll keep updating the situation as further information emerges. Peter Abraham of the Boston Globe notes (via Twitter) that the club is preparing to release a statement on the topic of Sale’s health.